Herpes Zoster With Trigeminal Nerve Distribution (Suspected Herpes Zoster Ophthalmicus)
Herpes zoster with facial rash confined to one side should be treated as a time-sensitive VZV infection. Treatment is most effective when initiated within 72 hours of symptom onset. [1] Suspected trigeminal distribution involvement requires prompt assessment for ocular involvement and urgent ophthalmology referral when ophthalmic disease is present. [2]
Medication Selection Algorithm
Oral antiviral therapy is recommended using one of the following options: [1], [2]
- Acyclovir (800 mg PO five times daily for 7 to 10 days). [2]
- Valacyclovir (1,000 mg PO three times daily for 7 or 14 days). [2]
- Famciclovir (500 mg PO three times daily for 7 days). [2] Intravenous acyclovir is recommended for immunocompromised patients requiring systemic therapy. [2]
Timing of Antiviral Therapy
Antiviral therapy should be started within 72 hours of rash onset. [1], [2]
Treatment Initiation Thresholds
Treatment should be initiated once herpes zoster is clinically suspected based on the characteristic unilateral rash distribution on the face. [1] Treatment is indicated to prevent progressive corneal involvement and potential vision loss when ophthalmic involvement is suspected. [1]
Monotherapy Versus Combination Therapy
Oral antiviral monotherapy with an appropriate dosing regimen is recommended as the core therapy for uncomplicated zoster skin disease. [1], [2] Analgesic therapy should be added for pain control. [2] Ocular-specific findings should drive additional ophthalmology-directed therapies rather than empiric eye-directed treatments. [2]
Adjunctive Care and Pain Management
Acute pain control is achieved with local care and oral analgesics. [2] Cool compresses and topical lubrication are used for palliative management of eyelid or conjunctival involvement. [2] Topical anesthetics should not be prescribed due to corneal toxicity. [2]
Ophthalmology Referral Triggers
Referral to an ophthalmologist is recommended when manifestations of ocular involvement or herpes zoster complications are present. [2]
Common Pitfalls to Avoid
Delay of antiviral therapy beyond the early treatment window reduces effectiveness for preventing ocular progression. [1], [2] Prescription of topical anesthetics should be avoided due to corneal toxicity. [2]
Targets and Goals of Therapy
Goals of antiviral therapy are acceleration of lesion resolution, reduction of new lesion development and viral shedding, and reduction of severity of acute pain. [1] Goals of early treatment in suspected ocular involvement are prevention of progressive corneal disease and potential vision loss. [1]